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Abstract One unifying explanation for the complexity of
Autism Spectrum Disorders (ASD) may lie in the disruption
of excitatory/inhibitory (E/I) circuit balance during critical
periods of development. We examined whether Parvalbumin
(PV)-positive inhibitory neurons, which normally drive
experience-dependent circuit refinement (Hensch Nat Rev
Neurosci 6:877–888, 1), are disrupted across heterogeneous
ASD mouse models. We performed a meta-analysis of PV
expression in previously published ASD mouse models and
analyzed two additional models, reflecting an embryonic
chemical insult (prenatal valproate, VPA) or single-gene
mutation identified in human patients (Neuroligin-3, NL-3
R451C). PV-cells were reduced in the neocortex across
multiple ASD mouse models. In striking contrast to controls,
both VPA and NL-3 mouse models exhibited an asymmetric
PV-cell reduction across hemispheres in parietal and occipital
cortices (but not the underlying area CA1). ASD mouse
models may share a PV-circuit disruption, providing new
insight into circuit development and potential prevention by
treatment of autism.
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A severe neurobehavioral syndrome with a heterogeneous
phenotype, autism spectrum disorders (ASD) are among the
most heritable neurodevelopmental disorders of early
childhood with an incidence as high as one child in 166.
ASD is primarily a genetic disorder of prenatal and early
postnatal brain development involving multiple risk genes,
disrupted epigenetic pathways and possible environmental
insults [2]. At present, there is no wholly effective treatment
nor is it understood which biological pathways are
specifically disrupted in individuals with autism. The
diagnostic indicators of autism are core behavioral symp-
toms, rather than definitive neuropathological markers.
Autistic children exhibit impaired language, abnormal
social interactions and repetitive behaviors. One third of
ASD patients have seizures and evidence of altered
inhibition in the brain [3].
One unifying explanation for the complexity of ASD
may lie in the disruption of excitatory/ inhibitory (E/I)
circuit balance during critical periods of development [4–6].
Neuronal circuits are refined by extraordinary levels of
plasticity during sensitive periods in early development,
which are diminished in adulthood. It is during these
“critical periods” that single neurons acquire multiple
functional properties through an experience-dependent
maturation. Recent findings have revealed that E/I circuit
dynamics can dictate the normal timing of critical periods
in brain development [1]. Gene-targeted deletion of a
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plasticity onset within the visual cortex indefinitely [7],
which can be rescued at any age with benzodiazepines [8].
Detailed local circuit analysis in vivo has further identified
a single GABAergic cell type — the Parvalbumin (PV)-
positive basket cell (Fig. 1) — as the key player for critical
period plasticity [9–11]. The calcium-binding protein PV
marks the largest class of inhibitory interneuron in the cortex
and makes up ~40% of the GABA cell population [12]. They
are born in the medial ganglionic eminence (MGE) on
embryonic day E13.5 [13] and can later be found throughout
the brain, including hippocampus, thalamus and cortex.
In neocortex, the two primary types of PV-cell are axon
initial segment-targeting chandelier cells and soma-targeting
large basket cells. The latter have a large, round soma with
several prominent radial dendrites. PVexpression begins near
postnatal day P12 in layer 5 and matures in an inside-out
laminar progression by around P21 in visual cortex and
somewhat earlier in somatosensory and other cortical regions
[12, 14]. With age, PV-cells become preferentially enwrapped
in chondroitin sulphate proteoglycans that form a perineuro-
nal net, which may buffer the ionic environment surrounding
these cells [15] or act to limit growth and sprouting of
impinging thalamic axon terminals [16]. Interestingly, remov-
al of these nets can reactivate critical period plasticity in adult
animals [17].
The mouse model system provides a method to experi-
mentallytest whether postnatal neurodevelopmental disorders
of human cognition involve dysfunction of such critically
timed activity-dependent processes. Mouse models of ASD
have been developed that reflect genetic alterations associated
with autism [18]. Some are based on monogenic aberrations
(Neuroligin-3, Neuroligin-4, MeCP2, TSC1/2, FMR1, ubiq-
uitin protein ligase 3A (Ube3A)) that underlie syndromes
associated with autistic-like behavior. Other mutant lines are
relevant to loci for autism susceptibility, identified by
association or linkage in human populations. Advances have
included the evaluation of mouse models with behavioral
assays designed to reflect disease symptoms, including
impaired social interaction, communication deficits and
repetitive behaviors, and symptom onset during the neonatal
period.
A meta-analysis of previously published reports reveals
that PV-cells are consistently reduced in the neocortex of
multiple mouse models of ASD (Table 1). Such a shared
circuit defect from heterogeneous genetic origins may
further our understanding of the complex etiology of ASD
and offers novel targets for therapeutic intervention. We
therefore examined a representative embryonic insult and
single-gene mutation model in greater detail from a PV-cell
perspective.
Global genetic perturbations are produced by prenatal or
neonatal environmental challenges, including early expo-
sure to the HDAC inhibitor valproic acid (VPA) or
inflammatory agents that have been suggested as autism
risk factors by clinical surveys. A robust model has
previously been developed in rats based on the fact that
treatment of epilepsy or bipolar disorder in pregnant
women around 20–24 days post-conception with the drug
VPA is linked to an increased incidence of ASD in their
children [19–21]. The physically healthy offspring of
pregnant rats treated with a single dose of VPA at an
equivalent gestational time point recapitulate the human
ASD phenotype [22, 23]. Related VPA mouse models have
been attempted, but most involve postnatal VPA treatment
not consistent with human studies [24, 25]. One group used
a slightly higher dose at a later time point, but they did not
evaluate behaviors implicated in autism [24].
Fig. 1 Specific GABA circuits
(large basket PV-cells) trigger a
developmental critical period.
PV, parvalbumin; CR, calretinin;
SOM, somatostatin; CCK,
cholecystokinin; a1-6, GABA-A
receptor a-subunit
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using the same dose at an equivalent injection time point and
evaluated behavior of the offspring [26, 27]. Five out of nine
VPA-injected pregnant females (500 mg/kg, i.p.) gave birth
to viable litters, and of these, two litters included some mice
with minor skeletal defects like bent tails and fused fingers.
We concluded that this dose was appropriate because it was
strong enough to have a teratogenic effect, but not too strong
to cause gross impairments. We then compared PV-cell
anomalies in the brain by immunostaining of VPA-treated
mice and a representative single-gene mutant of Neuroligin-3
(NL-3 R451C) reported to exhibit autistic features [28]
concomitant with enhanced cortical inhibitory synapse
function [6]. Note that an independently generated R451C
mutant mouse line revealed a different behavioral phenotype,
but was not characterized for expression of mutant NL-3 and
its electrophysiological consequences [29], making it unclear
how similar the line is to the original R451C mutant mice.
Common disruption of parvalbumin-positive GABA
circuits in ASD models
To determine whether our VPA mouse model shares a
similar disruption of inhibitory circuits with other mouse
models of ASD, we analyzed the distribution of PV-positive
interneurons in the brains of adult mice (>P60). In contrast
to the even distribution across the neocortex of control
animals, several areas in the neocortex of VPA-exposed
mice entirely lacked PV-cells or had substantially reduced
PV-cell numbers especially in the upper layers (Fig. 2a).
These zones of sparse or absent PV-cell labeling (“PV-
empty zones”) spanned several hundred micrometers in the
rostro-caudal extent and did not match any single modality
but rather partially affected several functional compart-
ments, such as the primary somatosensory and secondary
visual cortices. PV-empty zones were surrounded by areas
that displayed normal PV-cell densities.
The precise location and extent of PV-empty zones were
slightly variable among littermates that shared concomitant
prenatal VPA exposure, including a small subset that did
not exhibit any noticeable abnormality. However, the
majority of VPA-treated mice shared a common PV-empty
zone in a region around the caudal part of primary
somatosensory cortex. We therefore decided to analyze this
region quantitatively, by defining a region of interest
between Bregma −1.70 mm and −2.06 mm (rostro-caudal
level, Paxinos) in the upper half of the neocortex (see
Suppl. Fig. 1 and Methods for details). In order to
investigate whether the PV deficiency in the neocortex
was generally present in other brain regions, we analyzed
PV-cell numbers in the hippocampal CA1 area beneath the
affected cortex (same rostro-caudal level; see Suppl. Fig. 1
and Methods for details of the region of interest). We found
no significant difference of PV-cell densities in CA1
between VPA- and saline-treated animals (Fig. 2b).
Strikingly, PV-empty zones were primarily found to affect
onlyonehemisphere,whiletheneighboringhemisphereatthe
same rostro-caudal level seemed to be intact (Fig. 3a). We
therefore compared the visibly affected hemisphere of VPA
mice to either side of saline-treated control animals. This
analysis revealed a highly significant reduction of PV-cells
by prenatal VPA exposure (Fig. 2b). AlackofPV-cellsinone
but not the other hemisphere suggests a strong imbalance in
fast, perisomatic inhibition between the two sides of the brain.
To quantify the extent of this imbalance, we calculated the
interhemisphericratio(PV-cellnumberinthehemispherewith
lower density / PV-cell number in the opposite hemisphere).
While saline-exposed animals exhibited interhemispheric
ratios close to unity, VPA-exposed mice exhibited a robust
50% reduction of PV-cells in one of the two hemispheres. To
determine if this imbalance was general, we compared PV-cell
densities in the hippocampal CA1 region. No significant
difference in interhemispheric ratios between VPA- and
saline-treated mice were found in area CA1, indicating a
neocortex-specific deficit.
To address the possibility that the lack of PV-cells in
neocortex and an interhemispheric imbalance in inhibitory
circuits is a more robust hallmark of ASD models, we
investigated a single-gene mutation model of ASD, the
Gene/Condition Region Age Reference
FMRP somatosensory cortex P365 [94]
MeCP2 somatosensory cortex P14 [95]
CAPS2 motor cortex P17 [96]
uPAR anterior cingulate cortex parietal cortex >P90 [97]
NL-3 somatosensory cortex >P60 this study
VPA parietal cortex >P60 this study
prenatal immune challenge medial prefrontal cortex adult [98]
NPN2 hippocampus area CA3/CA1 >P60 [99]
En-2 hippocampus area CA3 P150 [100]
Table 1 PV-cell deficits across
ASD mouse models
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mutant mice exhibited very similar PV-cell deficiency and
interhemispheric imbalance as in the VPA model. NL-3
mutant mice were analyzed in the same way as described
above for prenatal VPA-treated animals. Once again, a
highly significant reduction of PV-cells in one hemisphere
was observed specific to the neocortex, as it was absent
from underlying CA1 (Fig. 2b). Inter-hemispheric ratios of
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Fig. 2 PV-cell deficit in VPA and NL-3 mutant mice. a Representa-
tive photomicrographs of PV immunohistochemistry in coronal
sections of saline-treated (SAL; top left), valproic acid-treated (VPA;
top right) Neuroligin3 wildtype (NL3 WT; bottom left) and mutant
(NL3 MUT; bottom right) mice. Scale bar: 500µm. b Quantitative
analysis of PV-cells in neocortex and hippocampal CA1 (see Suppl.
Fig. 1 and Mehods for details). For all animals, the hemisphere with
the lowest PV+ cell numbers was plotted. Note the specific reduction
of PV-cells in the neocortex of VPA-treated and NL3 mutant mice.
One-way ANOVA test: *** p<0.0001; Bonferroni multiple compar-
ison test, p<0.001; ns=not significant
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Fig. 3 Interhemispheric asymmetry of PV-cell deficit in VPA and
NL-3 mutant mice. a Representative photomicrographs of PV
immunohistochemistry in coronal sections of valproic acid treated
(VPA; top) and Neuroligin3 mutant (NL3 MUT; bottom) mice. Note
the difference in PV-cells in the two hemispheres. Scale bar: 500µm.
b Interhemispheric PV ratios calculated by dividing PV-cell numbers
in the two hemispheres at the same anterior-posterior level (ratio=
PV low density/PV high density hemisphere). One-way ANOVA
test: *** p<0.0001; Bonferroni multiple comparison test, p<0.001;
ns=not significant; SAL, saline control; WT, wild-type
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specifically in the neocortex (Fig. 3). Whether hemispheric
asymmetries of PV-cells are evident in other ASD mouse
models (Table 1) remains to be explored.
We further confirmed an increase of GAD65 puncta in the
NL-3 mutant (Suppl. Fig. 2), consistent with the original
report by Tabuchi et al [6]. Normally, PV regulates the
dynamics of calcium levels and GABA release during action
potential bursts in this specific interneuron subset [30].
Interestingly, PV knockout mice themselves have recently
been reported to exhibit autistic features (B. Schwaller,
personal communication). A loss of PV expression in VPA-
treated or NL-3 mutant mice may then exacerbate an E/I
imbalance in favor of inhibition [6], as in other models of
ASD (Table 1). Thus, disparate genetic origins may underlie
a common circuit defect in ASD.
Impact of PV-cell defects in ASD
Unlike principal excitatory neurons, GABAergic interneurons
comprise a diverse group that consists of dozens of different
types. Cortical interneuron subtypes can be classified by their
morphology, electrophysiological properties, molecular con-
tent and specific connectivity patterns. The PV-positive, large
basket cells have been implicated in two functions (Fig. 4): 1)
initiation of a critical period for cortical plasticity [1], and 2)
generation and synchronization of gamma (γ)-oscillations in
the hippocampus and neocortex [31]. Both phenomena have
been suggested to be impaired in the etiology of cognitive
developmentaldisorderssuchasASD,andcanstrikinglyboth
beaccounted for bythe commonPV-cell deficit reportedhere.
Critical periods
Hubel and Wiesel were among the first to find physiological
evidence for developmental time windows when specific
brain circuits are more susceptible to experience-dependent
changes[1]. Monocular occlusion of one eye produces a shift
of neuronal response (ocular dominance) in favor of the open
eye only when deprivation occurs during a specific ‘critical
period’. Since then critical periods have been identified
across a variety of brain regions, sensory systems and species
[32]. Electrophysiological recording and morphological
analyses in vivo in genetically manipulated mice have
furthered our understanding of the mechanisms and demon-
strated the importance of PV-cells.
Beginning with the discovery that GABA-deficient
GAD65 knockout mice do not initiate a critical period
and that this deficit could be rescued at any age with
diazepam [7, 8], the theory emerged that a requisite E/I
balance within the cortex enables plasticity at the appropri-
ate time (Fig. 4a). Diazepam is a positive allosteric
modulator of GABAA channels that binds specific subunits
to increase channel open probability and increase inhibi-
tion. Diazepam administration can prematurely open the
critical period of wild-type mice, but targeted point
mutation of the α1 receptor subunit prevents diazepam
binding as well as its precocious initiation of plasticity [9].
GABAA receptors containing the α1 subunit are located on
the soma-proximal dendrite region of pyramidal cells. PV-
large basket cells preferentially target the same area
(Fig. 1), which undergoes an experience-dependent regula-
tion of receptor number during the critical period [10]. The
non-cell autonomous homeoprotein Otx2 is crucial for the
ab
plasticity
postnatal age
Fig. 4 Two functions of PV-cells that might be altered in ASD mouse
models. a Initiation of critical periods of brain development may be
delayed or accelerated in specific regions exhibiting PV-cell deficits. b
Generation of γ-oscillations during cognition and sensory processing
may be dampened asymmetrically across hemispheres, potentially
impairing long-range synchronization and communication [64, 80,
81]. Adapted from ref. 61
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transcription factor for critical period initiation [11].
Taken together, these findings underscore the crucial
role PV-cells play in timing neocortical plasticity
(Fig. 4a), suggesting that PV-cell deficits may predictably
delay critical periods in specific ASD brain regions
(Table 1). Rescue of ASD models, such as the FMR1
knockout mouse by mGluR5 manipulation [33], can then
be reconsidered in terms of rebalancing PV-cell recruitment,
as mGluR5 is essential for long-term potentiation of
excitatory synapses onto these fast-spiking GABAergic
neurons [34]. Other direct strategies to enhance PV-cell
function, such as benzodiazepine agonists or the delivery of
Otx2 [11], may also prove fruitful. Conversely, to recali-
brate PV-cell discrepancies across hemispheres in adult
mice (Fig. 3), the administration of chondrotinases to
remove peri-neuronal nets that preferentially enwrap mature
PV-basket cells may be effective [17].
Gamma oscillations
EEG gamma (γ)-oscillations (30–80 Hz fluctuations of
neuronal activity) have received special attention because of
their suspected roles in “higher” cognitive functions such as
sensory binding [35], short-term memory storage [36]a n d
attention [37, 38]. γ-oscillations are prevalent in the hippo-
campus and sensory cortex and have been studied both in vivo
and in vitro. They are generated or reset in vivo by sensory
stimulation in mouse visual, auditory and somatosensory
cortex [39–41], exploratory behavior, sniffing in rodents,
visual attention in primates and during REM sleep [38, 42].
Persistent γ-oscillations can be stimulated in vitro with
carbachol to activate muscarinic cholinergic receptors or by
application of kainate to increase excitability of glutamatergic
receptors [43, 44]. They are also reliably generated in slices of
auditory and somatosensory cortex by thalamic stimulation,
but are short in duration (200–500 ms) [45].
Regardless of stimulus protocol, γ-oscillations can be
abolished by application of the GABAARa n t a g o n i s t
bicuculline [31]. Current-source density analysis combined
with voltage-dye imaging reveal an alternating current sink
and source near pyramidal cell somata, consistent with peri-
somatic inhibition during the oscillation [42]. When
excitatory drive is selectively reduced onto PV-cells either
by GluR-D knockout or conditional ablation of GluR-A
subunitoftheirAMPAreceptors,γ-powerisreduced[46], but
not when synaptic inhibition is ablated in PV-cells [47]. Most
recently, direct optical activation of PV-cells is shown to be
sufficient for inducing γ-rhythms and controlling sensory
responses to enhance cortical circuit performance [48, 49].
Both chandelier and large basket PV-cells are fast-spiking
(FS) cells that are interconnected via gap junctions and
inhibitory chemical synapses to form distributed networks.
FS-cells have short duration action potentialsand respond toa
depolarizing current with high frequency, non-adapting action
potential trains [51, 52]. PV-cells express Kv3.1 channels, a
class of inward rectifying K
+ channels that contributes to
their fast-spiking characteristics. PV-cells normally undergo
maturation of a number of intrinsic physiological properties
that contribute to their precise and rapid firing including an
experience-dependent increase in Kv3.1 channels [50], a
decrease in input resistance and action potential width and an
increase in action potential amplitude and frequency [53, 54].
Kv3.1 knockout mice exhibit an increase in γ-power, most
prominently during waking in the 40–55-Hz range [55].
Gap junctions strongly aid the synchrony and strength of
γ-oscillations, since the blockers octanol and carbexeno-
lone eliminate oscillations [56, 57], but deletion ofthe major
neuronal gap junction subunit, connexin 36, still allows weak
and less synchronous γ-oscillations both in vitro [58]a n din
vivo [59]. Careful study of the spike timing of different
classes of interneurons has shown that while both excitatory
and different classes of inhibitory neuron are capable of
firing phase-locked with the γ-oscillation, inhibitory neurons
a r em o r el i k e l yt ob es y n c h r o n i z e dw i t hF Si n t e r n e u r o n s
capable of firing on every cycle (Fig. 4b)[ 60, 61].
These findings lead to a model of a network of
interconnected inhibitory neurons, namely the PV-basket
cells, which generate the γ-oscillations [31]. Sensory
information is relayed from the environment and earlier
peripheral stages to the cortex via the thalamus. Thalamo-
cortical fibers target both principal cells and interneurons,
but input onto FS-cells is stronger than that onto excitatory
pyramidal cells [62]. Fast, precise inhibition provided by
the PV-cells allows a brief window for excitation of the
cortical network that is followed by an interval of strong
inhibition. Gap junctions and reciprocal chemical GABA
synapses connecting PV-cells meanwhile act as coincidence
detectors, amplifying synchronous excitatory currents and
dampening asynchronous inputs [63]. Asymmetrically
weakened PV-cell function in the ASD brain (Fig. 3) would
then be expected to have a powerful impact on sensory
processing and cognition [64].
Impaired oscillations in cognitive disorders
A dysregulation of oscillations could prevent discrimination
of intrinsic versus extrinsic signals [65]. In schizophrenic
subjects, abnormal γ-oscillations are thought to promote
hallucinations. Decreased GABA signaling is now well-
established in schizophrenia [66], which is seen not only as
a reduction of GABA concentration and GAD67 in
postmortem brain, but also as a restricted deficit of PV
staining [67, 68]. A specific association between disrupted
γ-oscillations, PV-cell reduction, and schizophrenic traits
has recently been demonstrated in the methyl azoxy-
J Neurodevelop Disord (2009) 1:172–181 177methanol acetate (MAM) model of schizophrenia. These
rats exhibit a specific loss of PV-cells in the prefrontal
cortex and a correlated lack of sound induced γ-oscillations
in the prefrontal cortex during a fear-conditioning task [69].
In auditory cortex of autistic adolescents, magneto-
encephalographic (MEG) recordings show a deficit of
evoked γ-oscillations phase-locked to the stimulus —
strikingly just in one hemisphere [70]. A similar finding
that the onset of γ-oscillations during a visual task is
disrupted in autism, suggests that there are signal-to-noise
processing problems [71, 72]. Of particular relevance is the
recent finding that visual attention preferentially modulates
FS interneurons in parietal areas [73], which we find are
prone to PV-cell deficits in ASD mouse models (Table 1).
Clinical studies suggest that decreased inhibitory input
and connectivity lead to altered synchronicity between
different brain regions, which may be a key contributing
factor to the features of ASD [35, 64, 74–76]. Consistent
anatomical evidence reveals narrower cortical minicolumns
in autistic patients [77–79] due to the loss of local inhibitory
projections[77]. This may result in further altered long-range
connectivity [80, 81], vital for communication between
neocortical modules and hemispheres [74, 82–85].
Interestingly, among several inbred strains [86], it is the
acallosal BTBR T+tf/J mouse that most closely exhibits
behavioral changes specific to autism, including reduced
social approach, altered ultrasonic vocalization, and resistance
to change in routine [87]. Moreover, network architecture and
synchronicity are altered in cultured neuronal networks
transfected with the autism-associated R451C NL-3 mutation
studied here [88]. The MeCP2-null hippocampal CA3 circuit
has diminished basal inhibitory rhythmic activity, which in
turn renders the circuitry prone to hyperexcitability [89].
Finally, a recent report demonstrates that γ-oscillations are
diminished in the FMR1 knockout mouse model of ASD
[90], consistent with their PV-cell deficit (Table 1).
Thus, studying γ-oscillation development in ASD mouse
models can serve as a useful readout of impaired PV-cell
network activity, which is now amenable to powerful, direct
molecular genetic manipulation [eg. 91]. Future work will
explore the hemispheric asymmetry in VPA or NL-3 mutant
mice described here, whether this can be rescued by
treatments aimed at restoring PV-cell balance [11, 17]a n d
ultimately reversing this heterogeneous neuro-developmental
disorder [92, 93].
Materials and methods
Animals
C57BL/6 females were mated overnight with C57BL/6
males and pregnancy was determined by the presence of a
vaginal plug on embryonic day E0. Valproic Acid (VPA)
solution was prepared from sodium salt of VPA (NaVPA;
Sigma-Aldrich, St. Louis, MO) and was dissolved in 0.9%
saline to a final concentration of 150 mg/mL at pH 7.3. At
E10.5, pregnant females were briefly anesthetized with
isofluorane and injected intraperitoneally with either a
single dose of VPA or 0.9% saline (control). Mice were
weighed prior to injection and the volume was adjusted for
a final dose of 500 mg/kg. This dose and time point is
identical to the conditions used in previous studies with rats
[22]. NL-3 R451C mice were bred, genotyped and
maintained as described previously [6]
Immunohistochemistry
Adult mice (2–3 months old) were transcardially per-
fused with ice-chilled 4% paraformaldehyde in PBS
(50 ml) and post-fixed overnight in the same solution
at 4°C. Sixty μm thick coronal sections were cut on a
Vibratome (Leica VT1000S). Free-floating sections were
permeabilized and blocked for 4 hours at room temper-
ature (RT) in 20% Bovine Serum Albumin (BSA) / 0.5%
TritonX100 in PBS. Sections were then incubated with
primary, rabbit anti-Parvalbumin (PV) (Swant) or GAD6
(DSHB, Iowa), and subsequently secondary, Alexa Fluor
546 (Invitrogen), antibodies (3–4 h each at RT, 1:500
(PV), 1:1000 (Alexa Fluor) in 5% BSA in PBS).
Between and after antibody incubations, sections were
washed 3x, 10 min each, in 5% BSA in PBS on a
shaker. Sections were then mounted in Vectashield Hard
Set (Vector Laboratories) and imaged.
Image acquisition and analysis
Images were acquired on a Nikon Eclipse 80i epifluores-
cent microscope equipped with a Coolsnap EZ camera
(Photometrics) and AR acquisition software (NIS Elements)
using a 4x air objective. Microscope images were processed
and analyzed using Photoshop (Adobe). For quantification,
images of the upper half of coronal brain sections, collected
between Bregma −1.70 mm and −2.06 mm (anterior-
posterior level, Paxinos), were taken (Suppl. Fig. 1). PV-
positive cells were counted in the neocortex and in the
hippocampal area CA1. Regions of interest were defined by
perpendicular lines along the upper blade and outer edge of
the dentate gyrus curve (Suppl. Fig. 1). PV-positive cells
were counted separately for the two hemispheres. Analysis
was performed blind to genotype or treatment by two
independent investigators.
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